Cited by 181Advanced Drug Delivery SystemsTissue Engineering and Regenerative MedicineNanoparticle-Based Drug Delivery

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations

Open access

Abstract

Implantable medical devices have revolutionized modern medicine. However, immune-mediated foreign body response (FBR) to the materials of these devices can limit their function or even induce failure. Here we describe long-term controlled-release formulations for local anti-inflammatory release through the development of compact, solvent-free crystals. The compact lattice structure of these crystals allows for very slow, surface dissolution and high drug density. These formulations suppress FBR in both rodents and non-human primates for at least 1.3 years and 6 months, respectively. Formulations inhibited fibrosis across multiple implant sites-subcutaneous, intraperitoneal and intramuscular. In particular, incorporation of GW2580, a colony stimulating factor 1 receptor inhibitor, into a range of devices, including human islet microencapsulation systems, electrode-based continuous glucose-sensing monitors and muscle-stimulating devices, inhibits fibrosis, thereby allowing for extended function. We believe that local, long-term controlled release with the crystal formulations described here enhances and extends function in a range of medical devices and provides a generalized solution to the local immune response to implanted biomaterials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41563-019-0377-5

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Siepmann, J., Siegel, R. A. & Rathbone, M. J. (eds) Advances in Delivery Science and Technology (Springer, 2012).

Cited by

Sorted by citations

See all 181

Metadata

Authors
Farah, S., Doloff, J. C., Müller, P., Sadraei, A., Han, H. J., Olafson, K., Vyas, K., Tam, H. H., Hollister-Lock, J., Kowalski, P. S., Griffin, M., Meng, A., McAvoy, M., Graham, A. C., McGarrigle, J., Oberholzer, J., Weir, G. C., Greiner, D. L., Langer, R., & Anderson, D. G.
Affiliations
  • Boston Children's Hospital (US)
  • Koch Institute for Integrative Cancer Research At MIT (US)
  • Harvard University (US)
  • University of Illinois Chicago (US)
  • Joslin Diabetes Center (US)
  • University of Massachusetts Chan Medical School (US)
Corresponding author
Anderson, Daniel G.
Venue
Nature Materials
Published
2019-06-24
Volume
18
Issue
8
Pages
892-904
ISSN
  • 1476-1122 (ISSN-L)
  • 1476-4660
OpenAlex
W2949742175
Cited by
181
References
61
Citations by year
2026: 20 · 2025: 23 · 2024: 25 · 2023: 27 · 2022: 20 · 2021: 38 · 2020: 23 · 2019: 5
FWCI
9.18
Type
journal article
Language
en
Open access
Locations
  • Nature Materials (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
  • eScholarship@UMassChan (submittedVersion)
Funders
  • National Institutes of Health (4r37eb000244-34, 1uc4dk104218-01)
  • National Cancer Institute (U54CA151884)
  • National Institute of Diabetes and Digestive and Kidney Diseases (UC4-DK-104218, R01DK091526, P30DK036836)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB000244, R37-EB000244, R01EB000351)
  • National Institute of Dental and Craniofacial Research (R01DE013023)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
foreign body reaction, controlled drug release, GW2580, anti-inflammatory drug delivery, biomedical implants, islet microencapsulation, continuous glucose monitoring
MeSH terms
Animals, Delayed-Action Preparations, Drug Compounding, Fibrosis, Macrophages, Rodentia, Prostheses and Implants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review